GSK PLC GSK shares inched up 0.20% to £15.31 Tuesday, on what proved to be an all-around favorable trading session for the ...

Dr. Pham Thi My Lien, president of GSK Vietnam, spoke with VIR’s Bich Thuy about the importance of adult vaccinations, one of ...

Pharmaceutical and biotechnology company GSK said on Tuesday that the European Medicine Agency has recommended meningococcal ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

Arexvy has been approved in Malaysia for RSV (respiratory syncytial virus), for older adults aged 60 and above. The vaccine ...

GSK plc (GSK, GSK.L) announced the European Medicine Agency's Committee for Medicinal Products for Human Use or CHMP has recommended ...

This tax demand was raised against HUL over non-deduction of TDS while making remittance payment for an acquisition from GSK ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

The application of IT for protecting and improving people’s health and the implementation of electronic medical records (EMR) ...

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 ...

GSK方面向记者证实，自今日（9 月 25 日）起，李卫东将加入GSK中国，就任副总裁、疫苗业务汇报负责人，直接向葛兰素史克（GSK）副总裁、中国总经理余慧明汇报。根据公开信息，李卫东在加入葛兰素史克之前为威斯克生物副总经理兼运营负责人。（21世纪经济报道） ...